avoca quality consortium meeting topics, day 1 may 6

1Avoca Quality Summit – Agenda – May 6, 2014 #AQCSummit2014

Consortium Members MeetingThe Westin Princeton at Forrestal Village

201 Village BoulevardPrinceton, NJ 08540

TOPICS MAY 6TH 2014

Overall Theme: Progress through Collaboration – Breaking Down Silos, Advancing Technology, and Building Bridges to Patients

10:30 AM - 11:00 AMRegistration and Continental Breakfast

Welcome and Overview of the Day

• Introduction, agenda and objectives • Patricia Leuchten, CEO, The Avoca Group

Reducing Risk, Improving Quality, and Enhancing Efficiency in the Identification and Selection of Third Party Providers

• This session will share the approach and progress being pursued by the Avoca Quality Consortium toinitiateaprocessforPre-Qualificationofthirdpartyorganizations.Conceptsincludeeasy,centralaccesstoRFIandqualificationinformationforcriticaltoquality(CTQ)parametersforhigh-riskdatageneratingniche-services.

• Moderated Consortium group discussion

Consortium Member Assessment Results

• This session will share interim results from the 2014 Avoca Quality Consortium Member Assessment Survey evaluating satisfaction and perception of quality delivered from service providers for outsourcedclinicalprograms.Thisyear’ssurveywillprovidelongitudinalanalysescomparing2014assessmentstopreviousresults.

• Moderated Questions/Answers

2Avoca Quality Summit – Agenda – May 6, 2014 #AQCSummit2014

Consortium Member Breakout Sessions

• Breakout1:ModerateddiscussionofMemberexperiencesworkingwiththeQualityConsortiumbest-practice Quality Oversight Guidelines and Tools, Quality Agreement Template, and Technology EnablerwhichprovidesaccesstoConsortiumMemberdocuments.Thesessionwillbestructuredasaninteractivesession,withsponsorMembersandCROMembersworkingtogetheronatopic,questionoranissuerelatedtothetools.

• Breakout2:ModeratedExecutiveMeetinginparalleltoBreakout1

Quality Metrics and a Focus on Enhancing Outcomes

• ThissessionwillsharetherefinementandenhancementoftheConsortiummetricstaxonomyandframeworktoensureacomprehensivesetofmetricsthatarelikelytohavemeasurableimpacttotheoutcomesforqualityinclinicalprograms.ThepresentationwillprovideinformationregardingprogresswiththeConsortium’smetricsbenchmarkingstudyanddatabase,includingmethodsofmeasurementandreportingforspecificmetrics.

• Moderated Consortium group discussion

“Big Data” to Inform Decisions in Clinical Trial Execution

• This session will be an interactive discussion regarding the use of “big data” to inform decisions in clinicaltrialexecution.ThesessionwillstartwiththepresentationofAvoca’s2014industrydataandthenwillproceedtoaninteractivediscussion.

Wrap-up and Closure

• Dinner